Hematopoietic recovery after IEV chemotherapy for malignant lymphoma followed by different cytokines can be monitored by analysis of G alpha 16 and CD34
M. Pfeilstocker et al., Hematopoietic recovery after IEV chemotherapy for malignant lymphoma followed by different cytokines can be monitored by analysis of G alpha 16 and CD34, AM J HEMAT, 64(3), 2000, pp. 156-160
The hematopoiesis-specific G protein alpha subunit G alpha 16 is a specific
element in the signal transduction of the early hematopoietic cytokine net
work. As G alpha 16 mRNA can be detected in early hematopoietic progenitor
cells, RT-PCR for G alpha 16 can be used as a sensitive marker of hematopoi
etic activity. The aim of this study was to test the possible use of Gale d
eterminations for monitoring cytokine effects on hematopoietic recovery aft
er chemotherapy in patients. We correlated presence of G alpha 16 mRNA and
CD34 surface antigen with hematopoietic recovery in six lymphoma patients u
ndergoing salvage therapy with different cytokine support (IEV followed by
G-CSF, IL-3, or placebo). Regardless of different cytokine schedules with d
ifferent time courses, hematopoietic recovery was always preceded by transc
ription of Gale, Monitoring the expression of Ga16 mRNA by RT-PCR is a high
ly sensitive diagnostic tool for analyzing hematopoietic recovery after che
motherapy and for characterizing the effects of cytokines on hematopoiesis.
(C) 2000 Wiley-Liss, Inc.